摘要 |
Disclosed are peptide and peptidomimetic compounds generally according to formula (I), and pharmaceutically acceptable salts thereof, that are useful as GHRP analogs: R<SUP>1</SUP>-A<SUP>2</SUP>-A<SUP>3</SUP>-A<SUP>4</SUP>-A<SUP>5</SUP>-R<SUP>2 </SUP>(I) or a pharmaceutically acceptable salt thereof, wherein: A<SUP>1 </SUP>is Aib, Apc or Inp; A<SUP>2 </SUP>is D-Bal, D-Bip, D-Bpa, D-Dip, D-1Nal, D-2Nal, D-Ser(Bzl), or D-Trp; A<SUP>3 </SUP>is D-Bal, D-Bip, D-Bpa, D-Dip, D-1Nal, D-2Nal, D-Ser(Bzl), or D-Trp; A<SUP>4 </SUP>is 2Fua, Om, 2Pal, 3Pal, 4Pal, Pff, Phe, Pim, Taz, 2Thi, 3Thi, Thr(Bzl); A<SUP>5 </SUP>is Apc, Dab, Dap, Lys, Orn, or deleted; R<SUP>1 </SUP>is hydrogen, (C1-6)alkyl, (C5-14)aryl, (C1-6)alkyl(C5-14)aryl, (C3-8)cycloakyl, or (C2-10)acyl; and R<SUP>2 </SUP>is OH or NH<SUB>2</SUB>; and pharmaceutical compositions and methods of use thereof.
|